01400nas a2200397   4500000000100000008004100001653001300042653002800055653001800083653004000101653001100141653001300152653002500165653001500190653001800205653001100223653001200234653001600246653001700262653001100279653003100290100001100321700001200332700001200344700001000356700001400366700001400380700001700394700001400411245010400425856007300529300001400602490000700616520036500623022001400988       2017                            d10aZoonoses10aVector-borne infections10aUnited States10aTuberculosis and other mycobacteria10aTravel10atourists10aRheumatoid arthritis10aNeuropathy10aMycobacterium10aMexico10aleprosy10aLepromatous10alepromatosis10aleprae10a16S ribosomal RNA gene PCR1 aVirk A1 aPritt B1 aPatel R1 aUhl J1 aBezalel S1 aGibson LE1 aStryjewska B1 aPeters MS00aMycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas.  uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652441/pdf/17-1104.pdf  a1864-18660 v233 a<p>We report Mycobacterium lepromatosis infection in a US-born person with an extensive international travel history. Clinical symptoms, histopathology, and management are similar to those of infections caused by M. leprae. Clinicians should consider this pathogen in the diagnosis of patients with symptoms of leprosy who have traveled to endemic areas.</p>
  a1080-6059